Table 2.

Primary and Secondary Outcomes as a Function of Treatment and Time of Measurement: Intention-to-Treat Analysis (N = 180).

	MORE (N=64)			CBT (N=64)			TAU (N=52)
Outcome	Pre	Post	es	Pre	Post	es	Pre	Post	es
PACS Craving	25.06 (1.97)	19.66 (1.78)	0.4**	22.82 (1.88)	22.36 (1.76)	0.0	25.68 (2.18)	23.59 (2.03)	0.1
PCL-C PTSD	36.07 (1.98)	31.56 (1.99)	0.3*	36.59 (1.89)	36.54 (1.96)	0.0	39.81 (2.19)	39.53 (2.26)	0.0
BSI Depression	12.91 (.79)	10.52 (.78)	0.4*	12.59 (.77)	10.78 (.83)	0.3*	13.95 (.85)	12.54 (.85)	0.2
BSI Anxiety	11.20 (.82)	9.65 (.76)	0.3*	10.78 (.78)	9.92 (.81)	0.1	12.27 (.89)	10.95 (.83)	0.2
FFMQ Mindfulness	125.30 (3.29)	138.79 (3.04)	0.5***	130.14 (3.06)	129.92 (2.91)	0.0	126.81 (3.64)	129.25 (3.49)	0.1
PANAS Positive Affect	34.16 (1.70)	40.08 (1.54)	0.5**	34.39 (1.59)	37.53 (1.52)	0.3*	31.49 (1.79)	32.82 (1.75)	0.1
PANAS Negative Affect	34.40 (1.88)	30.23 (1.74)	0.3*	32.60 (1.79)	32.88 (1.77)	0.0	36.37 (1.99)	36.05 (1.95)	0.0

Data are given as mean (SE). ES = within-group effect size (Hedge’s g).

^*p< .05 vs. pre-treatment within a treatment group

^**p≤.01 vs. pre-treatment within a treatment group

^***p≤.001 vs. pre-treatment within a treatment group